PubMed (RefSeq) for id: 1907093123

Year	Number of Results
1974	1
1994	1
1995	3
1996	1
1997	6
1998	1
1999	3
2000	3
2001	7
2002	5
2003	10
2004	11
2005	11
2006	13
2007	14
2008	17
2009	11
2010	20
2011	17
2012	20
2013	30
2014	27
2015	23
2016	21
2017	15
2018	15
2019	21
2020	16
2021	14
2022	7
2023	10
2024	4

1

Whole-exome sequencing in familial type 2 diabetes identifies an atypical missense variant in the RyR2 gene.

Bansal V, Winkelmann BR, Dietrich JW, Boehm BO. Bansal V, et al. Front Endocrinol (Lausanne). 2024 Feb 20;15:1258982. doi: 10.3389/fendo.2024.1258982. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38444585 Free PMC article.

2

Phosphorylation of RyR2 simultaneously expands the dyad and rearranges the tetramers.

Asghari P, Scriven DRL, Shahrasebi S, Valdivia HH, Alsina KM, Valdivia CR, Navarro-Garcia JA, Wehrens XHT, Moore EDW. Asghari P, et al. J Gen Physiol. 2024 Apr 1;156(4):e202213108. doi: 10.1085/jgp.202213108. Epub 2024 Feb 22. J Gen Physiol. 2024. PMID: 38385988

3

Genetic determinants of micronucleus formation in vivo.

Adams DJ, Barlas B, McIntyre RE, Salguero I, van der Weyden L, Barros A, Vicente JR, Karimpour N, Haider A, Ranzani M, Turner G, Thompson NA, Harle V, Olvera-León R, Robles-Espinoza CD, Speak AO, Geisler N, Weninger WJ, Geyer SH, Hewinson J, Karp NA; Sanger Mouse Genetics Project; Fu B, Yang F, Kozik Z, Choudhary J, Yu L, van Ruiten MS, Rowland BD, Lelliott CJ, Del Castillo Velasco-Herrera M, Verstraten R, Bruckner L, Henssen AG, Rooimans MA, de Lange J, Mohun TJ, Arends MJ, Kentistou KA, Coelho PA, Zhao Y, Zecchini H, Perry JRB, Jackson SP, Balmus G. Adams DJ, et al. Nature. 2024 Mar;627(8002):130-136. doi: 10.1038/s41586-023-07009-0. Epub 2024 Feb 14. Nature. 2024. PMID: 38355793 Free PMC article.

4

Foxp3-mediated blockage of ryanodine receptor 2 underlies contact-based suppression by regulatory T cells.

Wang X, Geng S, Meng J, Kang N, Liu X, Xu Y, Lyu H, Xu Y, Xu X, Song X, Zhang B, Wang X, Nuerbulati N, Zhang Z, Zhai D, Mao X, Sun R, Wang X, Wang R, Guo J, Chen SRW, Zhou X, Xia T, Qi H, Hu X, Shi Y. Wang X, et al. J Clin Invest. 2023 Dec 15;133(24):e163470. doi: 10.1172/JCI163470. J Clin Invest. 2023. PMID: 38099494 Free PMC article.

5

A dual-targeted drug inhibits cardiac ryanodine receptor Ca²⁺ leak but activates SERCA2a Ca²⁺ uptake.

Wegener JW, Mitronova GY, ElShareif L, Quentin C, Belov V, Pochechueva T, Hasenfuss G, Ackermann L, Lehnart SE. Wegener JW, et al. Life Sci Alliance. 2023 Nov 27;7(2):e202302278. doi: 10.26508/lsa.202302278. Print 2024 Feb. Life Sci Alliance. 2023. PMID: 38012000 Free PMC article.

6

Heart failure-induced cognitive dysfunction is mediated by intracellular Ca²⁺ leak through ryanodine receptor type 2.

Dridi H, Liu Y, Reiken S, Liu X, Argyrousi EK, Yuan Q, Miotto MC, Sittenfeld L, Meddar A, Soni RK, Arancio O, Lacampagne A, Marks AR. Dridi H, et al. Nat Neurosci. 2023 Aug;26(8):1365-1378. doi: 10.1038/s41593-023-01377-6. Epub 2023 Jul 10. Nat Neurosci. 2023. PMID: 37429912 Free PMC article.

7

An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor.

Reyes Gaido OE, Pavlaki N, Granger JM, Mesubi OO, Liu B, Lin BL, Long A, Walker D, Mayourian J, Schole KL, Terrillion CE, Nkashama LJ, Hulsurkar MM, Dorn LE, Ferrero KM, Huganir RL, Müller FU, Wehrens XHT, Liu JO, Luczak ED, Bezzerides VJ, Anderson ME. Reyes Gaido OE, et al. Sci Transl Med. 2023 Jun 21;15(701):eabq7839. doi: 10.1126/scitranslmed.abq7839. Epub 2023 Jun 21. Sci Transl Med. 2023. PMID: 37343080 Free PMC article.

8

Increased Ca²⁺ Transient Underlies RyR2-Related Left Ventricular Noncompaction.

Ni M, Li Y, Wei J, Song Z, Wang H, Yao J, Chen YX, Belke D, Estillore JP, Wang R, Vallmitjana A, Benitez R, Hove-Madsen L, Feng W, Chen J, Roston TM, Sanatani S, Lehman A, Chen SRW. Ni M, et al. Circ Res. 2023 Jul 7;133(2):177-192. doi: 10.1161/CIRCRESAHA.123.322504. Epub 2023 Jun 16. Circ Res. 2023. PMID: 37325910

9

RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure.

Fujii S, Kobayashi S, Chang Y, Nawata J, Yoshitomi R, Tanaka S, Kohno M, Nakamura Y, Ishiguchi H, Suetomi T, Uchinoumi H, Oda T, Okuda S, Okamura T, Yamamoto T, Yano M. Fujii S, et al. J Mol Cell Cardiol. 2023 May;178:36-50. doi: 10.1016/j.yjmcc.2023.03.007. Epub 2023 Mar 23. J Mol Cell Cardiol. 2023. PMID: 36963751

10

Genetic Inhibition of Mitochondrial Permeability Transition Pore Exacerbates Ryanodine Receptor 2 Dysfunction in Arrhythmic Disease.

Deb A, Tow BD, Qing Y, Walker M, Hodges ER, Stewart JA Jr, Knollmann BC, Zheng Y, Wang Y, Liu B. Deb A, et al. Cells. 2023 Jan 4;12(2):204. doi: 10.3390/cells12020204. Cells. 2023. PMID: 36672139 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

345 results

Results by year